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Introduction: Immune thrombocytopenia (ITP) is an acquired decrease of platelets, caused by autoantibodies against 
platelets, in the absence of an associated condition. ITP is associated to low morbidity and mortality, however there is 
reduced quality of life on the patients under treatment. This study has as objectives to describe the clinical features of the 
patients and the evaluation of risk factors related to the response to treatment. 
Methods: A retrospective analysis was achieved, regarding the medical records of 99 patients diagnosed with ITP and 
seen between May of 1992 and August of 2016 in a hospital. 
Results: 99 patients were analyzed, 71 female (71.7%). Mean age 39 years old to diagnosis (variation 2-84). 83.3% of the 
patients were chronic ITP and the mean follow up 49.2 months (0,1-289). 74.7% of patients presented bleeding to diagnosis. 
76.7% of patients required treatment, and there was remission in 7 (30.4%) of the 23 patients who did not receive any 
treatment. 37 patients were submitted to splenectomy, 30 (81.1%) of those obtained partial or complete response and 18 
(48.6%) presented loss of response. 30% of patients were submitted to posterior treatments. Only two patients had death 
related to ITP. In bivariate analysis of risk factors to response to the treatment, the only predictors of chronicity were initially 
the absence of corticosteroid dependence and absence of response to splenectomy, however in multivariate analysis those 
factors had their significance discarded. 
Conclusion: The presented results did not confirm a higher progression rate to chronicity in non corticosteroid-dependent 
patients and in those who did not present response to splenectomy. The clinical features, response pattern and survival of 
analyzed patients were similar to other studies reported. 
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